FTRE CLASS ACTION: A Class Action was filed against Fortrea Holdings Inc. for Securities Fraud — Contact BFA Law by August 1 Legal Deadline (NASDAQ:FTRE) GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea […]
IOVA CLASS ACTION: A Class Action was filed against Iovance Biotherapeutics for Securities Fraud — Contact BFA Law by July 14 Legal Deadline (NASDAQ:IOVA) GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics,
ELV CLASS ACTION: A Class Action was filed against Elevance Health, Inc. for Securities Fraud — Contact BFA Law by July 11 Legal Deadline (NYSE:ELV) GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance
AAPL CLASS ACTION: A Class Action was filed against Apple Inc. for Securities Fraud — Contact BFA Law by August 19 Legal Deadline (NASDAQ:AAPL) GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Apple Inc.
The following issues have been halted by CIRO Company: Lupaka Gold Corp. TSX-Venture Symbol: LPK All Issues: Yes Reason: Pending News Halt Time (ET): 8:40 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and
STUDIO CITY, Calif., July 02, 2025 (GLOBE NEWSWIRE) — The International Myeloma Foundation (IMF) and the collaborative stakeholder group i2TEAMM (International Independent Team for Endpoint Approval of Myeloma MRD), which includes top global myeloma experts, proudly announce the positive outcome of the i2TEAMM's application on the use of minimal residual disease (MRD) as an early
The International Myeloma Foundation Proudly Announces EMA-CHMP Positive Qualification Advice to i2TEAMM Novel Biomarker Procedure Application on the Use of MRDnegCR as an Intermediate Early Endpoint for Conditional Market Approval in Myeloma Clinical Trials Another Remarkable Milestone for the IMF and i2TEAMM, Following the FDA-ODAC Unanimous 12-0 Vote in April 2024 GlobeNewswire July 02, 2025
StartupScience.io, a platform dedicated to founder success and startup growth, has acquired Startup Stack, a curated platform that offers early-stage startups access to over 300 software deals totaling more than $3.5 million in savings. This acquisition strengthens StartupScience.io's mission to democratize entrepreneurship by embedding Startup Stack's trusted resource directly into its broader founder-focused ecosystem. Known
National DRESS Syndrome Day 2025 Highlights “Faces of DRESS” to Advocate for Urgent Scientific Investment In honor ofNational DRESS Syndrome Dayon July 16, the DRESS Syndrome Foundation is calling out the urgent need for funding into an overlooked yet life-threatening condition: DRESS Syndrome. DRESS stands for Drug Reaction with Eosinophilia and Systemic Symptoms, and is
(NYSE:HIMS), NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Hims & Hers,